Rate My Professor Oun Al-Iedani

Al-Iedani's research specializes in advanced MRI and MRS techniques, including data post-processing, FAST MRSI, image processing, in vivo diffusion studies, applied particularly to multiple sclerosis and gliomas. He has attracted significant funding, leading 11 grants totaling over $699,000, such as the Multi-modal MRI for personalised MS progression prediction ($225,000 from MS Australia, 2025-2027), Using amide proton transfer weighted-MRI to investigate grade 4 gliomas ($120,000 from Mark Hughes Foundation, 2024-2026), and Longitudinal improvement of white matter networks in MS ($5,000 HMRI, 2024). His prolific output includes 27 peer-reviewed journal articles and 37 conference presentations. Key publications feature "Exploring the Role of Advanced MRI in Understanding Glioblastoma Biology: A Scoping Review" (Cancers, 2026), "Neurometabolic changes in multiple sclerosis: Fingolimod versus beta interferon or glatiramer acetate therapy" (Journal of Neuroimaging, 2022), "Improvement of the thalamocortical white matter network in people with stable treated relapsing-remitting multiple sclerosis over time" (NMR in Biomedicine, 2024), and "Fast magnetic resonance spectroscopic imaging techniques in human brain—applications in multiple sclerosis" (Journal of Biomedical Science, 2017). Al-Iedani supervises PhD students on MS neuroimaging and obstructive sleep apnoea, and serves on the editorial board of BMC Medical Imaging. Through collaborations with researchers like Assoc. Prof. Saadallah Ramadan and Conjoint Prof. Jeannette Lechner-Scott, his work enhances predictive models for MS progression and brain tumor biology, impacting clinical neuroimaging practices.